These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2440059)

  • 1. [Potential antiangiogenic substances from alpha,alpha'-bis(amidinobenzyl)cycloalkanone derivatives and alpha-(arylsulfonylamino)-omega-phenylcarboxylic acid-4-amidinoanilide].
    Teuscher E; Vieweg H; Wagner G
    Pharmazie; 1987 Feb; 42(2):109-10. PubMed ID: 2440059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A possible explanation of mechanisms inducing inhibition of vascularization of tumours by antifibrinolytic drugs--the influence of migratory behaviour of endothelial cells.
    Teuscher E; Pester E
    Biomed Biochim Acta; 1984; 43(4):447-56. PubMed ID: 6207812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical control of hyperfibrinolytic states by synthetic inhibitors of fibrinolytic enzymes.
    Markwardt F; Klöcking HP
    Biomed Biochim Acta; 1983; 42(6):725-30. PubMed ID: 6605748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Synthesis of antiproteolytically active 3,5-bis(4-amidinobenzyl)- and 3,5-bis(4-amidinobenzylidene)piperidone-(4) derivatives (author's transl)].
    Richter P; Wagner G
    Pharmazie; 1980 Feb; 35(2):75-7. PubMed ID: 7384187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Attempts to prepare 4-amidinophenyl- or 4-amidinobenzyl-alpha-dicarbonyl derivatives].
    Richter P; Wagner G
    Pharmazie; 1977 Apr; 32(4):213-20. PubMed ID: 896908
    [No Abstract]   [Full Text] [Related]  

  • 6. [Proliferation of cultured endothelial cells under the effect of aprotinin and 4-aminomethylbenzoic acid].
    Pilgrim H; Grosse S
    Biomed Biochim Acta; 1986; 45(8):1015-9. PubMed ID: 2430560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Synthesis of alpha-alpha'-Bis-[amidinobenzylides]-and alpha-alpha'-Bis-[amidinobenzyl]-cycloalkanones].
    Wagner G; Vieweg H; Horn H
    Pharmazie; 1977 Mar; 32(3):141-5. PubMed ID: 866380
    [No Abstract]   [Full Text] [Related]  

  • 8. [Quantum chemical studies on substituted benzamidines as inhibitors of the serine proteinases trypsin and thrombin].
    Henkel HJ; Labes D; Hagen V
    Pharmazie; 1983 May; 38(5):342-6. PubMed ID: 6611634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of benzamidine derivatives as inhibitors of clotting enzymes.
    Wagner G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):67-74. PubMed ID: 6177610
    [No Abstract]   [Full Text] [Related]  

  • 10. [Synthesis of N-alpha-(tosylglycylprolyl)-4-amidinophenylalanine amides as thrombin inhibitors].
    Voigt B; Wagner G
    Pharmazie; 1986 Jun; 41(6):378-81. PubMed ID: 3763680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of glandular and plasma kallikrein by benzamidine derivatives.
    Stürzebecher J; Vieweg H; Prasa D
    Agents Actions Suppl; 1992; 38 ( Pt 1)():190-7. PubMed ID: 1466270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Synthetic inhibitors of serine proteinases. Part 25: Inhibition of trypsin, plasmin and thrombin by amides of N alpha-substituted amidinophenylalanines and 3-amidinophenyl-3-aminopropionic acids (author's transl)].
    Stürzebecher J; Horn H; Markwardt F; Wagner G; Walsmann P
    Pharmazie; 1981 Sep; 36(9):639-41. PubMed ID: 6458047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoic acid and interferon alpha act synergistically as antiangiogenic and antitumor agents against human head and neck squamous cell carcinoma.
    Lingen MW; Polverini PJ; Bouck NP
    Cancer Res; 1998 Dec; 58(23):5551-8. PubMed ID: 9850093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The action of fibrinolysis inhibitors of the omega-aminocarboxylic acid type on the proliferation of in vitro cultured endothelial cells].
    Pilgrim H
    Pharmazie; 1986 Jul; 41(7):519-20. PubMed ID: 3490674
    [No Abstract]   [Full Text] [Related]  

  • 15. [The pharmacodynamics of synthetic thrombin inhibitors of the basic type substituted n-alpha arylsulfonylated phenylalanine amide].
    Kaiser B; Hauptmann J; Markwardt F
    Pharmazie; 1987 Feb; 42(2):119-21. PubMed ID: 3602050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of benzamidine-type thrombin inhibitors.
    Hauptmann J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):89-97. PubMed ID: 6177614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aromatic tetra-amidines: antiproteolytic and antiesterolytic activities towards serine proteinases involved in blood coagulation and clot lysis.
    Ferroni R; Menegatti E; Orlandini P; Guarneri M; Taddeo U; Bolognesi M; Ascenzi P; Bertollini A; Amiconi G
    Farmaco Sci; 1986 Jun; 41(6):464-70. PubMed ID: 3527742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of 4-aminomethylbenzoic acid (PAMBA) on the proliferation of in vitro cultured endothelial cells of the calf aorta].
    Pilgrim H; Ebert C
    Pharmazie; 1985 Mar; 40(3):196-7. PubMed ID: 3875107
    [No Abstract]   [Full Text] [Related]  

  • 19. N alpha-arylsulfonyl-omega-amidinophenyl-alpha-aminoalkyl-carboxylic acid amides as specific thrombin inhibitors.
    Stürzebecher J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):83-8. PubMed ID: 6177613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel bis(benzamidino) compounds with an aromatic central link. Inhibitors of thrombin, pancreatic kallikrein, trypsin, and complement.
    Geratz JD; Cheng MC; Tidwell RR
    J Med Chem; 1976 May; 19(5):634-9. PubMed ID: 1271404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.